Drug Formulation & Characterization
Our pharmaceutical unit has comprehensive knowhow about small molecules, biologics and ingredients.
We are in the forefront of disease model development with a variety of immune, iPSC-derived and immortalized cell line-based models.
We produce, purify and characterize recombinant proteins using prokaryotic and eukaryotic gene expression systems.
We offer a broad spectrum of technologies from single cell analysis to complex histology and specialized RNA in situ detection.
Research & Development
The R&D strategy of Bioneer is focused on therapeutic fields where novel solutions are required to fulfill societal needs. Treatments of the future require that patients can be segmented, that specific disease pathogenesis can be explained, that mode-of-action mechanisms can be understood and that therapeutic modalities are tailored to provide optimal treatment effects.
Bioneer welcomes novel collaborations and encourages potential collaborators to contact Bioneer.
The R & D Program Includes:
- Microbiome in Health and Disease – new models and tools for microbiome and probiotic investigations
- Inflammatory Conditions – new services for complex inflammatory analysis
- Predictive 3D Cell Models – establishment of bioprinted human and rodent cell models
- Patient-Specific Drug Formulation – a range of new models for individualized drug formulation
- Protein Manufacturing – developing and refining protein manufacturing technologies
- Industrial Mediator – Big Science Facilities – facilitating access to neutron– and X-Ray facilities
Research & development
The R&D strategy of Bioneer for 2016 and onwards is focused on therapeutic fields where novel solutions are required to fulfill societal needs. Treatments of the future requires that diseases can be segmented, that mode-of-action patterns of diseases can be understood and that therapeutic modalities are tailored to provide optimal treatment effects with a minimum of sideeffects.
In order to execute parts of this demanding research program Bioneer receives an annual grant from the Danish Ministry of Education and Research which alongside with Danish and international industrial grants, and internal funding forms the financial basis for realizing the program.
Bioneer welcomes novel collaborations and encourage potential collaboratiors to contact bioneer.
The R & D program includes:
Precision medicine –– new biomarker tools for the health care sector
Immune modulation – a range of new immunological services
Patient specific cell models – a range of 3D cell models based on human cells
Rational drug development – a range of in vitro methods to increase the succes rate of development of potential drug candidates
Protein manufacturing and membrane proteins – developing and refining protein manufacturing technologies
Meet us at
Create new product opportunities
We offer access to essential tools, technology and unique biological resources within cell and molecular biology.